Inhibitory effect of a histamine 4 receptor antagonist on CCL17 and CCL22 production by monocyte-derived Langerhans cells in patients with atopic dermatitis

Journal of Dermatology

Volumn 43, Issue 9, 2016, Pages 1024-1029

  Miyano, Kyohei ^a   Matsushita, Sho ^a   Tsuchida, Tetsuya ^a   Nakamura, Koichiro ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

atopic dermatitis; chemokines; histamine 4 receptor antagonist; Langerhans cells; peptidoglycan

Indexed keywords

1 (5 CHLORO 2 INDOLYLCARBONYL) 4 METHYLPIPERAZINE; HISTAMINE H4 RECEPTOR; MACROPHAGE DERIVED CHEMOKINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PEPTIDOGLYCAN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TOLL LIKE RECEPTOR 2;

ADULT; ARTICLE; ATOPIC DERMATITIS; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LANGERHANS CELL; MALE; TH2 CELL;

EID: 84985998631     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/1346-8138.13294     Document Type: Article

References (20)

1. Kakinuma T, Nakamura K, Wakugawa M et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001; 107: 535–541.
2. Kakinuma T, Nakamura K, Wakugawa M et al. Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis. Clin Exp Immunol 2002; 127: 270–273.
3. Hashimoto S, Nakamura K, Oyama N et al. Macrophage-derived chemokine (MDC)/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis. J Dermatol Sci 2006; 44(2): 93–99.
4. Dijkstra D, Stark H, Chazot PL et al. Human inflammatory dendritic epidermal cells express a functional histamine H4 receptor. J Invest Dermatol 2008; 128: 1696–1703.
5. Mommert S, Gschwandtner M, Koether B, Gutzmer R, Werfel T. Human memory Th17 cells express a functional histamine H4 receptor. Am J Pathol 2012; 180(1): 177–185.
6. Mommert S, Dittrich-Breiholz O, Stark H, Gutzmer R, Werfel T. The histamine H4 receptor regulates chemokine production in human natural killer cells. Int Arch Allergy Immunol 2015; 166: 225–230.
7. Suwa E, Yamaura K, Sato S, Ueno K. Increased expression of the histamine H4 receptor following differentiation and mediation of the H4 receptor on interleukin-8 mRNA expression in HaCaT keratinocytes. Exp Dermatol 2014; 23(2): 138–140.
8. Gschwandtner M, Rossbach K, Dijkstra D et al. Murine and human Langerhans cells express a functional histamine H4 receptor modulation of cell migration and function. Allergy 2010; 65: 840–849.
9. Ohsawa Y, Hirasawa N. The antagonism of histamine H1 and H4 receptors ameliorates chronic allergic dermatitis via anti-pruritic and anti-inflammatory effects in NC/Nga mice. Allergy 2012; 67: 1014–1022.
10. Kaesler S, Volz T, Skabystka Y et al. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10. J Allergy Clin Immunol 2014; 134(1): 92–99.
11. Wollenberg A, Rawer HC, Schauber J. Innate immunity in atopic dermatitis. Clin Rev Allergy Immunol 2011; 41: 272–281.
12. Mrabet-Dahbi S, Mauer M. Innate immunity in atopic dermatitis. Curr Probl Dermatol 2011; 41: 104–111.
13. Niebuhr M, Mamerow D, Heratizadeh A, satzger I, Werfel T. Staphylococcal α-toxin induces a higher T cell proliferation and interleukin-31 in atopic dermatitis. Int Arch Allergy Immunol 2011; 156: 412–415.
14. Brauweiler AM, Goleva E, Leung DY. Th2 cytokines increase Staphylococcus aureus alpha toxin induced keratinocyte death through the signal transducer and activator of transcription 6 (STAT6). J Invest Dermatol 2014; 134: 2114–2121.
15. Travers JB, Kozman A, Mousdicas N et al. Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid. J Allergy Clin Immunol 2010; 125: 146–152.
16. Aliahmadi E, Gramlich R, Grutzkau A et al. TLR2-activated human langerhans cells promote Th17 polarization via IL-1β, TGF-β and IL-23. Eur J Immunol 2009; 39: 1221–1230.
17. Rajkovic I, Dragicevic A, Vasilijic S et al. Differences in T-helper polarizing capacity between human monocyte-derived denrticic cells and monocyte-derived langerhans' –like cells. Immunology 2011; 132: 217–225.
18. Kwon DJ, Bae YS, Ju SM et al. Casuarinin suppresses TARC/CCL17 and MDC/CCL22 production via blockade of NF-κB and STAT1 activation in HaCaT cells. Biochem Biophys Res Commun 2012; 417: 1254–1259.
19. Qi XF, Kim DH, Yoon YS et al. The adenylyl cyclase-cAMP system suppresses TARC/CCL17 and MDC/CCL22 production through p38 MAPK and NF-kappaB in HaCaT keratinocytes. Mol Immunol 2009; 46: 1925–1934.
20. Kurokawa M, Matsukura S, Kawaguchi M et al. Interleukin-33-activated dendritic cells induce the production of thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Arch Allergy Immunol 2013; 161(Suppl 2): 52–57.